Drug Shortage Report for TARO-LENALIDOMIDE
| Report ID | 222084 |
| Drug Identification Number | 02507862 |
| Brand name | TARO-LENALIDOMIDE |
| Common or Proper name | lenalidomide |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LENALIDOMIDE |
| Strength(s) | 2.5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 3 x 7 |
| ATC code | L04AX |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-09-12 |
| Estimated end date | 2024-03-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-03-13 | French | Compare |
| v1 | 2024-03-13 | English | Compare |
Showing 1 to 2 of 2